Tandem | Latest News & Updates - Feb 06, 2025 Release
Tandem's insulin pump is part of a new UVA clinical trial testing AI-powered automated insulin delivery technology...
Brought to you by RivalSense - an AI tool for monitoring any company.
RivalSense tracks the most important product launches, fundraising news, partnerships, hiring activities, pricing changes, tech news, vendors, corporate filings, media mentions, and other developments of companies you're following 💡


Tandem
🌎 withtandem.comTandem is a technology company based in New York, NY, focused on accelerating access to medicine through the application of AI. It aims to build the world's largest network of doctors, patients, and first-party data to bring new therapies to market efficiently. Tandem also offers a prescription concierge service that checks prescriptions against insurance prices and various payment options, ensuring patients receive their medications quickly and affordably.
Tandem - Latest News and Updates
- Tandem's insulin pump is part of a new UVA clinical trial testing AI-powered automated insulin delivery technology.
- Tandem is hiring a Founding Designer.
- Tandem, led by Co-founder & CEO Christophe Barre, is the first AI success agent for SaaS that proactively guides users and has been integrated by multiple unicorn companies to enhance user adoption.
Sign up to receive regular updates
If you liked the insights, consider following your own companies of interest. Receive weekly insights directly to your inbox using RivalSense.
